Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practice

Completed

• Conditions: colorectal cancer; gastric cancer and breast cancer; 10017991

• Registration Number: NL-OMON36444
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 90

Inclusion Criteria

Cancer patients starting with capecitabine

Exclusion Criteria

younger than 18 year

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Adherence rate; a patient is adherent with the intake of 85% or more of the<br /><br>prescribed medication. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Number and grade of side-effects according to patients experience<br /><br>Attitude towards disease<br /><br>Beliefs and attitude towards medicines</p><br>